A Guideline for Healthcare Professionals From the American Heart Association/American Stroke Association AHA/ASA 2012 AHA/ASA scientific statements Care of the Patient With Acute Ischemic Stroke ...

The application fee for SSC Phase 13 is Rs 100 for General and OBC candidates. However, female aspirants and candidates belonging to other categories are exempted from paying the examination fee.

A private lunar lander from Japan is closing in on the moon's unexplored far north, carrying an unusual piece of cargo - a miniature red house.

The 38-year-old beauty has revealed that she briefly dated Craig, 36, before the TV star's relationship ... Kristin - who was married to former NFL star Jay Cutler between 2013 and 2022 - said: "I was ...

The private ispace Resilience lander will land on the moon at 3:17 p.m. EDT today (June 5), but only if the company pursues its prime landing spot. Here's why. Update for 5 p.m. ET: The Japanese ...

Ageing may well be a bereavement – but if it is, we have to start moving out of the denial phase of grief if we’re ever going to reach acceptance.

The ENLIGHTEN program consists of two Phase 3 clinical trials, ENLIGHTEN 1 and ENLIGHTEN 2, to evaluate the efficacy and safety of LYR-210 for the treatment of CRS. While the ENLIGHTEN 2 trial met ...

Investigator Dan Long of the Jackson Police Department led the investigation. Police recovered video surveillance from the incident, which showed Hulsey being lured to a hotel room on the second ...

CARLSBAD, Calif. – June 2, 2025 – Beginning later this year, GIA (the Gemological Institute of America) will start using descriptive terms to characterize the quality of laboratory-grown diamonds and ...

India is entering a bold new phase in 2022. From infrastructure and innovation ... system to counter escalating Chinese threat Japan's Moon landing dream crashes, again 10 Countries Where Locals ...

WALTHAM, Mass., May 31, 2025 (GLOBE NEWSWIRE) -- Xilio Therapeutics, Inc. (Nasdaq: XLO), a clinical-stage biotechnology company discovering and developing tumor-activated immuno-oncology therapies ...